BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12699071)

  • 1. Pleiotropic effects of statins: how important are they in the prevention of vascular disease?
    Mehta JL
    Endothelium; 2003; 10(1):3-4. PubMed ID: 12699071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protein isoprenylation].
    Jamroz-Wisniewska A; Bełtowski J
    Postepy Biochem; 2004; 50(4):316-29. PubMed ID: 15957527
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation.
    Li DY; Chen HJ; Mehta JL
    Cardiovasc Res; 2001 Oct; 52(1):130-5. PubMed ID: 11557241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction.
    Li D; Mehta JL
    Endothelium; 2003; 10(1):17-21. PubMed ID: 12699073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging mechanisms for secondary cardioprotective effects of statins.
    Miller SJ
    Cardiovasc Res; 2001 Oct; 52(1):5-7. PubMed ID: 11557228
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.
    Cho KJ; Hill MM; Chigurupati S; Du G; Parton RG; Hancock JF
    Mol Cell Biol; 2011 Mar; 31(6):1110-20. PubMed ID: 21245384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins: definitive translational research.
    Grundy SM
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S20-3. PubMed ID: 25549229
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
    Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
    Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statins on low-density lipoprotein size: a new role in cardiovascular prevention?
    Rizzo M; Berneis K
    South Med J; 2006 Sep; 99(9):1015-6. PubMed ID: 17004543
    [No Abstract]   [Full Text] [Related]  

  • 13. The antioxidant effects of statins.
    Davignon J; Jacob RF; Mason RP
    Coron Artery Dis; 2004 Aug; 15(5):251-8. PubMed ID: 15238821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.
    Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL
    J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Rho in cardiovascular disease.
    Laufs U; Liao JK
    Circ Res; 2000 Sep; 87(7):526-8. PubMed ID: 11009552
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells.
    Li D; Singh RM; Liu L; Chen H; Singh BM; Kazzaz N; Mehta JL
    Cardiovasc Res; 2003 Jan; 57(1):238-43. PubMed ID: 12504834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of statins. - Basic research and clinical perspectives -.
    Zhou Q; Liao JK
    Circ J; 2010 May; 74(5):818-26. PubMed ID: 20424337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.